Need public description.

  • Cannabis (Cannabis sativa)

None listed

None listed

None listed

None listed
ID Subject of Study Study Name Name Type Overall Effect Enzymes Transporters Object Object Metabolite Precipitant
NPDI-P9f-Mw Cannabis (Cannabis sativa) Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Decreased systemic exposure of Theophylline with Smoked Marihuana (non Tobacco smoker) In Vivo Interaction positive — PK Interaction – Increased systemic exposure
theophylline medicinal cannabis
NPDI-6t3-aw Cannabis (Cannabis sativa) Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Decreased systemic exposure of Theophylline with Smoked Tobacco (no Marihuana smoker) In Vivo Interaction positive — PK Interaction – Decreased systemic exposure
theophylline medicinal cannabis
NPDI-yqEgVA Cannabis (Cannabis sativa) Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel Docetaxel PK ± medicinal cannabis In Vivo Interaction negative — No Effect (based on bioequivalence limits)
  • CYP3A
docetaxel medicinal cannabis
NPDI-RUuAkA Cannabis (Cannabis sativa) Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Decreased systemic exposure of Theophylline with Smoked Marihuana (Tobacco smoker) In Vivo Interaction positive — PK Interaction – Decreased systemic exposure
theophylline medicinal cannabis
NPDI-4ZUTtw Cannabis (Cannabis sativa) Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel Irinotecan PK ± medicinal cannabis In Vivo Interaction negative — No Effect (based on bioequivalence limits)
  • CYP3A
irinotecan medicinal cannabis